Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Growth Projections For The Vaccine Contract Manufacturing Market Size During 2025–2029?
The vaccine contract manufacturing market size has seen substantial growth over recent years. Its valuation is projected to expand from $3.58 billion in 2024 to $3.88 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 8.4%. The factors contributing to this market’s expansion in past periods include restrictions in traditional vaccine manufacturing, global disease outbreaks stimulating the need for vaccines, governmental support for contract manufacturing, the rising complexity involved in vaccine creation, and a surge in the fields of vaccine research and development.
The vaccine contract manufacturing market is projected to experience substantial growth in the coming years. It is set to expand to $5.78 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 10.4%. This expansion during the forecast period is attributable to an increasing emphasis on pandemic preparedness, a rise in outsourcing within pharmaceutical manufacturing, the growth of biopharmaceutical companies, accelerated vaccine development timelines, and global initiatives promoting vaccine accessibility. Prominent trends for this period include the integration of single-use technologies in manufacturing, an increase in personalized medicine approaches to vaccine development, the advancement of mRNA and viral vector vaccines, the adoption of continuous manufacturing processes, and the broadening of fill-finish services.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12216&type=smp
Which Drivers Are Shaping The Vaccine Contract Manufacturing Industry’s Market Share?
Future expansion of the vaccine contract manufacturing market is anticipated due to a rise in pro-vaccination endeavors. Vaccination constitutes a straightforward, secure, and effective means of preventing infectious diseases. It strengthens the immune system, enhancing the body’s resistance to infections. A greater number of initiatives supporting vaccinations would facilitate the progression and refinement of diverse vaccine manufacturing processes, thereby supporting vaccine contract manufacturing. As an illustration, in November 2022, the U.S. Department of Health and Human Services, a cabinet-level executive branch department of the US federal government, unveiled a new $350 million program targeting HRSA (Health Resources and Services Administration)-supported health centers to elevate COVID-19 vaccine uptake in their localities, particularly focusing on underserved populations. Consequently, the uptick in initiatives promoting vaccinations is fueling the expansion of the vaccine contract manufacturing market.
What Are The Segment Types Shaping The Vaccine Contract Manufacturing Market?
The vaccine contract manufacturingmarket covered in this report is segmented –
1) By Service Type: Fill-Finish; Bulk Product
2) By Vaccine Type: Inactivated Vaccines; Live-Attenuated Vaccines; RNA (Ribonucleic Acid) Vaccines; Subunit Vaccines; Toxoid-Based Vaccines
3) By Process: Downstream; Upstream
4) By Scale Of Operation: Preclinical; Clinical; Commercial
5) By End-Use: Human Use; Veterinary
Subsegments:
1) By Fill-Finish: Aseptic Fill-Finish; Lyophilization; Vial Filling; Syringe Filling
2) By Bulk Product: Cell Culture; Microbial Fermentation; Antigen Production; Buffer Preparation
What Are The Latest Industry Trends Transforming The Vaccine Contract Manufacturing Market?
Strategic alliances represent a significant evolving trend within the vaccine contract manufacturing industry. Leading companies are forming collaborations with businesses active in the vaccine contract manufacturing domain to maintain their standing in the market. As an illustration, in January 2023, Vaxxas, an Australian biotechnology company focused on developing innovative needle-free vaccination technology, collaborated with the Coalition for Epidemic Preparedness Innovations (CEPI), a foundation based in Norway. This partnership’s objective is to finance and coordinate the creation of new vaccines and foster the advancement of Vaxxas’ needle-free vaccine patch delivery technology in a venture that may remove the need for frozen storage of mRNA vaccines. Additionally, in October 2024, LenioBio, a German Biotech firm, teamed up with ReciBioPharm, a US-based contract development and manufacturing organization (CDMO), to expand its protein manufacturing capabilities and quicken vaccine production. This collaboration is consistent with LenioBio’s plan to extend the scope of its CEPI-supported project, which aims to demonstrate the swiftness and efficiency of its unique ALiCE protein expression technology in producing proteins related to vaccines for use in clinical trials.
Who Are The Top Performing Companies In The Vaccine Contract Manufacturing Market In Recent Years?
Major companies operating in the vaccine contract manufacturing market include Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Fujifilm Holdings Corporation, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Icon plc, Lonza Group AG, Cytiva, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Albany Molecular Research Inc., Soligenix Inc., Bio Farma, Curia Global Inc., Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L
Download The Full Report For Exclusive Market Findings:
Which Region Currently Holds The Largest Share Of The Vaccine Contract Manufacturing Market?
North America was the largest region in the vaccine contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Vaccine Contract Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12216&type=smp
Browse Through More Reports Similar to the Global Vaccine Contract Manufacturing Market 2025, By The Business Research Company
Orphan Drug Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report
Drug Delivery Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Autoimmune Disease Diagnosis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model